miR-206 regulates non-small cell lung cancer cell aerobic glycolysis by targeting hexokinase 2.
Aerobic glycolysis was closely associated with the malignant transformation and prognosis of tumors. miR-206 was found to be downregulated in several cancers. However, whether miR-206 functions in NSCLCs via the process of aerobic glycolysis remains poorly characterized. qRT-PCR was performed to detect miR-206 level in NSCLC cells and tissues. The effect of miR-206 on hexokinase 2 (HK2) expression was examined through miR-206 overexpression or miR-206 knockdown. CCK-8 assay and colony formation assay were carried out to explore the role of miR-206 on cell proliferation and colony formation, respectively. The relationship between miR-206 and HK2 was measured by Dual-luciferase reporter assay. Glucose consumption, lactate production assay and ATP generation were performed in NSCLC cells following miR-206 and HK2 overexpression. We found that miR-206 was downregulated in NSCLC tissues and cells. miR-206 overexpression downregulated the expression of HK2 via targeting HK2 3'UTR in NSCLC cells. In addition, miR-206 decreased the cell viability and colony formation in NSCLC cells. Furthermore, miR-206 reduced glucose uptake, lactate production and ATP generation in NSCLC cells via HK2 repression. In conclusions, these findings suggested that miR-206 regulated NSCLC cell aerobic glycolysis by targeting HK2.